🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Reviva Pharmaceuticals Holdings, Inc. (RVPH)
OTCMKTS · Delayed Price · Currency is USD
0.3000
-0.0550 (-15.49%)
At close: Nov 18, 2026

RVPH Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-19.86-29.92-39.26-28.26-8.52
Stock-Based Compensation
2.231.633.410.180.15
Other Operating Activities
-0.09-0.720.240.19-1.59
Change in Accounts Payable
-3.412.290.333.01-0.5
Change in Other Net Operating Assets
-3.46-6.836.965.92-0.2
Operating Cash Flow
-24.59-33.54-28.32-18.96-10.67
Operating Cash Flow Growth
-----

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
0.410.980.67--
Total Debt Issued
0.410.980.67--
Short-Term Debt Repaid
-0.46-0.52-0.67--
Total Debt Repaid
-0.46-0.52-0.67--
Net Debt Issued (Repaid)
-0.050.46---
Issuance of Common Stock
25.6123.1933.177.7931.6
Financing Cash Flow
25.5623.6533.177.7931.6

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
0.96-9.894.85-11.1720.93

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Levered Free Cash Flow
-17.14-21.54-14.01-8.54-6.87
Unlevered Free Cash Flow
-17.13-21.52-13.99-8.54-6.87

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.010.020.03--
Cash Income Tax Paid
000.02-0
Change in Working Capital
-6.87-4.547.288.93-0.7